Running Projects

Cancer Genomics and Epigenetics Core Group

Home > Teams > Genomic Instability and Cancer > Cancer Genomics and Epigenetics Core Group > Running Projects

Running Projects

Examining genome wide transcriptomic and epigenetic changes related to Small Cell Lung Cancer (SCLC) phenotype transition.
Integrative transcriptome analysis of SCLC tumor and cell line data to predict survival and drug response.
Identifying drug response and survival predictors from tumor samples.
Characterization of oncogenic amplifications in SCLC.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

Awards

Consortium

About HCEMM

Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.

National VAT number: 26307383-2-06
EU VAT number: HU26307383

Internal Policies

Contact Info

Copyright © 2024 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.